Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Exome Asset Management LLC
Form 13F · Q2 2026

Exome Asset Management LLC

CIK 2011932申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$1.6亿
申报组合市值
52
持仓数量
11
Quarters on record
Top 50
持仓数量

Exome Asset Management LLC——持仓

共 52 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1GH Guardant Health Inc67,500−18.4%$1013万6.2%
2PRAX Praxis Precision Medicines I27,205−40.2%$911万5.6%
3TGTX Tg Therapeutics Inc164,915—$906万5.6%
4COGT Cogent Biosciences Inc210,523−24.4%$815万5.0%
5IONS Ionis Pharmaceuticals Inc88,177−19.9%$699万4.3%
6LLY Eli Lilly & Co5,492−21.7%$659万4.1%
7ABVX Abivax Sa46,878—$625万3.9%
8ALMS Alumis Inc204,418−26.8%$575万3.5%
9CYTK Cytokinetics Inc60,056−42.1%$512万3.2%
10ELVN Enliven Therapeutics Inc100,203−54.5%$509万3.1%
11VERA Vera Therapeutics Inc97,276−15.4%$417万2.6%
12UNH Unitedhealth Group Inc9,612−25.3%$400万2.5%
13TXG 10X Genomics Inc102,629−33.4%$393万2.4%
14NTRA Natera Inc13,800−26.0%$375万2.3%
15QURE Uniqure Nv81,056—$373万2.3%
16RYTM Rhythm Pharmaceuticals Inc32,209−20.6%$358万2.2%
17MAZE Maze Therapeutics Inc114,692+29.6%$342万2.1%
18GLUE Monte Rosa Therapeutics Inc137,115−23.6%$332万2.0%
19MLTX Moonlake Immunotherapeutics166,493−22.7%$324万2.0%
20ALKS Alkermes Plc61,336−27.1%$321万2.0%
21LQDA Liquidia Corporation39,224−14.4%$313万1.9%
22UTHR United Therapeutics Corp Del5,410−23.3%$293万1.8%
23GKOS Glaukos Corp19,862−4.8%$278万1.7%
24ARWR Arrowhead Pharmaceuticals In32,214−29.5%$263万1.6%
25AGIO Agios Pharmaceuticals Inc70,500−43.6%$262万1.6%
26CBIO Crescent Biopharma Inc.127,769−16.6%$230万1.4%
27AZN Astrazeneca Plc12,045—$225万1.4%
28BSX Boston Scientific Corp48,347+0.0%$206万1.3%
29ADAG Adagene Inc488,293−33.7%$205万1.3%
30PEN Penumbra Inc6,300+0.0%$199万1.2%
31ISRG Intuitive Surgical Inc4,908−22.8%$195万1.2%
32VKTX Viking Therapeutics Inc47,861—$187万1.2%
33OCUL Ocular Therapeutix Inc181,588—$178万1.1%
34EQ Equillium Inc552,956—$177万1.1%
35ASND Ascendis Pharma A/S6,573—$175万1.1%
36CRBP Corbus Pharmaceuticals Hldgs184,914−21.0%$173万1.1%
37CTMX Cytomx Therapeutics Inc.460,067−11.8%$173万1.1%
38VSTM Verastem Inc429,041−32.6%$164万1.0%
39NKTR Nektar Therapeutics22,417—$156万1.0%
40CLPT Clearpoint Neuro Inc83,636—$149万0.9%
41INSM Insmed Inc13,873−47.9%$148万0.9%
42CAI Caris Life Sciences Inc78,180—$139万0.9%
43BBIO Bridgebio Pharma Inc18,359−72.8%$137万0.8%
44ZBIO Zenas Biopharma Inc52,443−35.0%$133万0.8%
45NBP Novabridge Biosciences576,960+0.0%$113万0.7%
46ESTA Establishment Labs Hldgs Inc13,100+0.0%$112万0.7%
47RLAY Relay Therapeutics Inc47,531−82.9%$89万0.5%
48GERN Geron Corp624,046—$80万0.5%
49DRUG Bright Minds Biosciences Inc10,110—$71万0.4%
50CMPX Compass Therapeutics Inc276,165—$60万0.4%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。